Dr. Tarik Benidir, FRCSC, MD, MS

Dr. Benidir practices at Cleveland Clinic Main Campus in Cleveland, Ohio.

Dr. Benidir's NPI, 1952971905, was assigned on June 30, 2021. Dr. Benidir graduated from Queens University in 2016. Dr. Benidir holds Florida license ME161900.

Dr. Benidir's primary practice is Cleveland Clinic Main Campus, at 9500 Euclid Ave, Cleveland, OH 44106 in Cuyahoga County. The practice phone is (216) 986-1314.

Dr. Benidir's primary practice is Cleveland Clinic Main Campus in Cleveland, Ohio. Dr. Benidir is also affiliated with UF Health Shands Hospital. The medical group on file is UF Health Physicians.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Benidir practices. Vendor and product names are available with a free account.

Urology is Dr. Benidir's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Benidir is board certified in urology by the American Board of Urology. Dmand AI has Dr. Benidir's licenses on file in 2 states: Florida and Ohio.

Dmand AI lists bladder disease, kidney stone disease, transurethral procedures, urinary endoscopy and UTI among the conditions Dr. Benidir treats.

CMS data shows 1,479 Medicare services from Dr. Benidir across 15 procedure codes in 2024, for 231 Medicare patients. Medicare paid $49,322 for them.

CMS counts 231 Medicare patients who saw Dr. Benidir in 2024. The largest group is 65 to 74, with 111 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.64, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Benidir's median patient age at 74, with 18% women.

In 2024, Dr. Benidir wrote 57 Medicare Part D claims for 31 patients. 67% of them were for generic drugs. CMS names the drug for 17 of them, across 1 drug with 11 or more claims each, at $43,575 in total drug cost. In 2023, CMS named 15 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 48 out of 100 for Dr. Benidir for performance year 2024, reported through an alternative payment model (APM). Dr. Benidir accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Benidir as offering telehealth.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 9 papers to Dr. Benidir, published from 2018 to 2025. 2024 was the busiest year, with 4. The most frequent topics are Kidney Neoplasms, Artificial Intelligence and Carcinoma, Transitional Cell. Dr. Benidir has published most often in Urol Oncol. Dr. Benidir's most frequent co-authors are Samuel Carlton Haywood, MD, Jihad H. Kaouk, MD and Robert Abouassaly, MD.

CMS Open Payments shows 36 general payments to Dr. Benidir from 7 drug and device companies from 2022 to 2025. Consulting fees make up the largest share, 73% of the total. KOELIS Inc. paid the most, $8,238.

Dr. Benidir graduated from Queens University in 2016.

Dr. Benidir is in network with 16 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.